November 20, 2020
The measles-mumps-rubella (MMR) vaccine has been theorized to provide protection against COVID-19. In a new study published in mBio, an open-access journal of the American Society for Microbiology, researchers provide further proof of this by showing that mumps IgG titers, or levels of IgG antibody, are inversely correlated with severity in recovered COVID-19 patients previously vaccinated with the MMR II vaccine produced by Merck Read more
Reading level: Grade 12
EurekAlert!, the online, global news service operated by AAAS, the science society
Please Give Us Feedback!

Why are you reading this article? (check all that apply)







How do you feel about science?







Send Feedback
Free science fair projects.